The federal judges rejected arguments by two former employees of SmithKline Beecham Co. that pharmaceutical reps cannot be classified as “outside salesmen” — individuals who make sales and obtain orders primarily away from the company’s office. According to the court, pharmaceutical reps fit this definition.
The court decision focused on the definition of ‘sales.’ Federal law prohibits drug companies from selling products directly to the public, meaning individuals must use a prescription from a physician. Pharmaceutical reps visit physicians to persuade them to prescribe company products rather than those sold by competitors.
Read the Arizona Daily Star report on pharmaceutical reps.
Read more on drug manufacturers:
–FDA, Johnson & Johnson Clash Over Rejection of Sedative
–House Hears Arguments Over FDA’s Device Approval Process
–5 Ways Surgery Centers Can Maximize the Benefits of Their Membership With a GPO
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
